glp-1 drugs news Fmr. FDA Commissioner weighs in on Medicare's involvement in prices World Health Organization recommends GLP-1

Diabetes Obes Metab (2021) 23 Suppl 3:529

Curry is known for his experience in minimally invasive bariatric surgery, his leadership in outpatient weight loss surgery, and his commitment to helping patients choose the treatment option that best fits their medical needs and long-term goals

Concomitant use with metformin, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, or insulin targets multiple pathways involved in glucose metabolism

GLP-1 agonist weight loss medications like Wegovy and Saxenda have a high probability of causing thyroid cancer based on available evidence These medications were originally designed for diabetes and then repurposed for weight loss, which means the long-term thyroid safety data is still limited The potential benefits of GLP-1 agonists for weight loss must be carefully weighed against the significant risk of developing thyroid cancer If you're considering these medications, have a detailed conversation with your doctor about your personal thyroid cancer risk versus the weight loss benefits Do the most popular weight loss medications of our time like Wegovy and Saxenda cause thyroid cancer